Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, any side effects from Mounjaro begin within the first few hours to two days after an injection, with nausea being the most commonly reported and usually appearing on day one. The pattern settles for many people within one to two weeks. Mounjaro (tirzepatide) is a prescription-only medicine; a clinician assesses your full health picture before it is prescribed, and that assessment is the right place to discuss your individual risk profile.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
People often expect Mounjaro to behave like a painkiller — something you take and feel within minutes. The reality is more measured. The most common side effects are gastrointestinal: nausea, occasional vomiting, loose stools, constipation, indigestion and belching. These tend to surface in the first one to two days after an injection, typically peaking on day one or two, then easing as the level of the medicine in your body settles across the week.
The misconception worth letting go gently is that feeling sick on week one means you'll feel sick every week. For a good number of people, the body adjusts within two to four weeks. The discomfort isn't a sign that something is wrong with you specifically; it reflects how the medicine slows gastric emptying, which is part of how it reduces appetite. A fuller breakdown of Mounjaro's side-effect profile puts each symptom in context.
The NHS tirzepatide medicines page confirms that nausea is the most common effect and that it is generally mild to moderate. If you are wondering how soon Mounjaro side effects tend to appear, eating smaller portions, staying upright after injecting and choosing a low-fat meal on injection day can all take the edge off.
Mounjaro treatment starts at 2.5 mg. That opening strength exists partly to let your system acclimatise — not to produce therapeutic weight loss immediately. Many people sail through it with little trouble. Others notice some nausea on days one or two that fades by the weekend.
When the prescriber moves you to the next strength, the timeline effectively resets. A step up can bring a brief return of symptoms that had already settled. This is normal and usually shorter-lived than the first round. The full licensed schedule runs from 2.5 mg up to 15 mg in 2.5 mg increments, each typically held for at least four weeks before any increase, though your prescriber decides the pace based on your response.
Fatigue and headache in the first day or two after an injection are also reported, and are listed on the Mounjaro SmPC on the eMC alongside the GI effects. Injection-site redness or mild discomfort is possible too; rotating sites (abdomen, thigh, upper arm) and using a fresh needle each time keeps this manageable. If you want detail on one particular part of the journey, the Mounjaro overview page covers the full picture.
Most side effects are an inconvenience rather than a danger. A few are not. Know the difference.
In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. The signal to act on is severe stomach pain that comes on suddenly, persists and may radiate toward the back, with or without vomiting. That is not a symptom to manage at home, call 111 or go to A&E.
Seek same-day medical advice for any of the following: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat), symptoms suggesting significant dehydration from repeated vomiting or diarrhoea (dizziness, very dark urine, confusion), gallbladder pain (sharp pain under the right ribs), or low mood and thoughts of self-harm. Our Mounjaro side effects page lists the full range, with guidance on which symptoms are self-manageable and which are urgent. You can also contact our aftercare team seven days a week with questions once you are being treated through nume.
A question our prescribers hear regularly is whether specific circumstances change when side effects hit. Travel is one example: changing time zones does not alter the medicine's behaviour in your body, but the disruption to eating patterns and sleep can make nausea feel more noticeable. Mounjaro and flying covers what to bear in mind before a long-haul trip.
Physical activity can occasionally intensify GI symptoms if you exercise hard shortly after injecting. A simple fix: inject in the evening if your mornings are active. None of this is a reason to avoid treatment; it is a reason to plan around it.
If you are considering starting Mounjaro and want to understand how soon after your first injection side effects are likely to begin, speaking to our prescribers as part of a free consultation is the practical next step. A real clinician reviews your answers the same day (not software) and suitability, timing and managing any effects are all part of that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.